Q97784057

Summary

Q97784057 is an individual motion^[1].

Key Facts

• Q97784057 authored Penilla Gunther^[2].
• Q97784057's instance of is recorded as individual motion^[3].
• Q97784057's part of the series is recorded as motions of 2012-2013 legislative session of the Riksdag^[4].
• Q97784057's language of work or name is recorded as Swedish^[5].
• Q97784057 was released on +2012-10-03T00:00:00Z^[6].
• Q97784057's main subject is medication^[7].
• Q97784057's work available at URL is recorded as http://data.riksdagen.se/dokument/H002So368^[8].
• Q97784057's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H002So368^[9].
• Q97784057's applies to jurisdiction is recorded as Sweden^[10].
• Q97784057's legal citation of this text is recorded as Mot. 2012/13:So368^[11].
• Q97784057's title is recorded as Finansiering av särläkemedel för sällsynta sjukdomar^[12].
• Q97784057's copyright status is recorded as public domain^[13].
• Q97784057's legislative committee is recorded as Committee on Health and Welfare^[14].

Body

Definition and Type

Q97784057's instance of is recorded as individual motion^[3].